Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -910 | -580 | -300 | -1,250 | -940 |
| Depreciation Amortization | 70 | 50 | 20 | 40 | 10 |
| Other Working Capital | -250 | -210 | -130 | 270 | 280 |
| Other Operating Activity | 60 | 0 | 10 | 210 | 200 |
| Operating Cash Flow | $-1,030 | $-740 | $-400 | $-730 | $-450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -10 | -9 | -10 | 0 |
| Other Investing Activity | -1,560 | -1,810 | -1,841 | -90 | -50 |
| Investing Cash Flow | $-1,570 | $-1,820 | $-1,850 | $-100 | $-50 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,740 | 1,750 | 1,760 | 1,480 | 1,470 |
| Financing Cash Flow | $1,740 | $1,750 | $1,760 | $1,480 | $1,470 |
| Exchange Rate Effect | 1 | 10 | 7 | 10 | 0 |
| Beginning Cash Position | 1,060 | 1,060 | 1,060 | 410 | 410 |
| End Cash Position | 200 | 250 | 570 | 1,060 | 1,370 |
| Net Cash Flow | $-860 | $-810 | $-480 | $650 | $960 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,030 | -740 | -400 | -730 | -450 |
| Free Cash Flow | -1,030 | -740 | -400 | -730 | -450 |